Current Report Filing (8-k)
January 13 2022 - 4:07PM
Edgar (US Regulatory)
false 0001828735 --12-31 0001828735 2022-01-07 2022-01-07 0001828735 bene:UnitEachConsistingOfOneClassaCommonStockOneRightAndThreeFourthRedeemableWarrantMember 2022-01-07 2022-01-07 0001828735 bene:ClassACommonStockParValue0.0001PerShareMember 2022-01-07 2022-01-07 0001828735 bene:RightsExchangeableIntoOneTenthOfOneShareOfClassACommonStockMember 2022-01-07 2022-01-07 0001828735 bene:WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember 2022-01-07 2022-01-07
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 7, 2022
Benessere Capital Acquisition Corp.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-39836
|
|
85-3223033
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
78 SW 7th Street, Unit 800
Miami, FL 33130
(Address of principal executive offices, including zip code)
Registrant’s telephone number, including area code: (561) 467-5200
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
Units, each consisting of one share of Class A Common Stock, one Right and three-fourths of one Redeemable Warrant
|
|
BENEU
|
|
The NASDAQ Stock Market LLC
|
Class A Common Stock, par value $0.0001 per share
|
|
BENE
|
|
The NASDAQ Stock Market LLC
|
Rights, exchangeable into one-tenth of one share of Class A common Stock
|
|
BENER
|
|
The NASDAQ Stock Market LLC
|
Redeemable Warrants, each whole warrant exercisable for one share Class A Common Stock for $11.50 per share
|
|
BENEW
|
|
The NASDAQ Stock Market LLC
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01. Entry into a Material Definitive Agreement.
On January 12, 2022, Benessere Capital Acquisition Corp. (the “Company”) issued promissory notes (the “Notes”) in the aggregate principal amount of $2,065,897.80 to each of ARC Global Investments LLC (the “Sponsor”) and eCombustible Energy LLC (“eCombustible”), pursuant to which each of the Sponsor and eCombustible loaned to the Company $1,032,948.90 to deposit into the Company’s trust account for each share of the Company’s Class A common stock (“Public Share”) that was not redeemed in connection with the extension of the Company’s termination date from January 7, 2022 to July 7, 2022.
The Company will deposit the funds into the Company’s trust account and such amount will be distributed either to: (i) all of the holders of Public Shares upon the Company’s liquidation or (ii) holders of Public Shares who elect to have their shares redeemed in connection with the consummation of the Company’s initial business combination.
The Notes bear no interest and are repayable in full upon the earlier of (a) the date of the consummation of the Company’s initial business combination, or (b) the date of the liquidation of the Company.
The issuance of the Notes was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
The foregoing description is qualified in its entirety by reference to the Notes, copies of which are attached as Exhibit 10.1 and Exhibit 10.2 hereto and are incorporated herein by reference.
Item 2.03. Creation of a Direct Financial Obligation or an Obligation Under an Off-balance Sheet Arrangement of a Registrant.
The disclosure contained in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 2.03.
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On January 7, 2021, the Company filed an amendment to the Company’s Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware (the “Extension Amendment”). The Extension Amendment extends the date by which the Company must consummate its initial business combination from January 7, 2022 to July 7, 2022.
The foregoing description is qualified in its entirety by reference to the Extension Amendment, a copy of which is attached as Exhibit 3.1 hereto and is incorporated by reference herein.
Item 5.07. Submission of Matters to a Vote of Security Holders.
On January 7, 2022, the Company held a special meeting of stockholders (the “Meeting”). At the Meeting, the Company’s stockholders approved the Charter Amendment extending the date by which the Company must consummate its initial business combination from January 7, 2022 to July 7, 2022 (the “Extension Amendment Proposal”).
The final voting results for the Extension Amendment Proposal were as follows:
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
Broker Non-Votes
|
10,299,350
|
|
78,011
|
|
7,404
|
|
0
|
Stockholders holding 1,170,511 shares of the Company’s Class A common stock exercised their right to redeem such shares for a pro rata portion of the funds in the Company’s trust account. As a result, approximately $11,886,421.46 (approximately $10.15 per share) will be removed from the Company’s trust account to pay such holders.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. The following exhibits are filed with this Form 8-K:
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benessere Capital Acquisition Corp.
|
|
|
|
|
|
Dated: January 13, 2022
|
|
|
|
|
|
By:
|
|
/s/ Patrick Orlando
|
|
|
|
|
|
|
|
|
Name: Patrick Orlando
|
|
|
|
|
|
|
|
|
Title: Chief Executive Officer
|
Benessere Capital Acquis... (NASDAQ:BENEU)
Historical Stock Chart
From Jun 2024 to Jul 2024
Benessere Capital Acquis... (NASDAQ:BENEU)
Historical Stock Chart
From Jul 2023 to Jul 2024